The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma

The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma

Recurrent glioblastoma (rGBM) is a highly aggressive form of brain cancer that poses a significant challenge for treatment in neuro-oncology, and the survival status of patients after relapse usually means rapid deterioration, thus becoming the leading cause of death among patients. In recent years,...

Full description

Bibliographic Details
Main Authors: Xudong Liu, Zihui Zhao, Wufei Dai, Kuo Liao, Qi Sun, Dongjiang Chen, Xingxin Pan, Lishuang Feng, Ying Ding, Shiyou Wei
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
recurrent glioblastoma
immunotherapy
CAR-T therapy
immune checkpoint inhibitor
cancer vaccine
oncolytic viral therapy
Online Access:https://www.mdpi.com/2072-6694/15/17/4308

Internet

https://www.mdpi.com/2072-6694/15/17/4308

Similar Items